Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
2.960
-0.040 (-1.33%)
At close: Nov 20, 2024, 4:00 PM
2.900
-0.060 (-2.03%)
Pre-market: Nov 21, 2024, 5:48 AM EST
Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $4.46 million. The enterprise value is -$12.68 million.
| Market Cap | 4.46M |
| Enterprise Value | -12.68M |
Important Dates
The next estimated earnings date is Friday, November 29, 2024, after market close.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 1.51 million shares outstanding. The number of shares has increased by 136.81% in one year.
| Current Share Class | 1.51M |
| Shares Outstanding | 1.51M |
| Shares Change (YoY) | +136.81% |
| Shares Change (QoQ) | +58.13% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.76% |
| Float | 1.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.24 |
| P/TBV Ratio | 0.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.03
| Current Ratio | 7.03 |
| Quick Ratio | 6.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.22% and return on invested capital (ROIC) is -24.96%.
| Return on Equity (ROE) | -37.22% |
| Return on Assets (ROA) | -21.98% |
| Return on Capital (ROIC) | -24.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$790,500 |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.41% in the last 52 weeks. The beta is 0.80, so GLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -39.41% |
| 50-Day Moving Average | 4.69 |
| 200-Day Moving Average | 4.24 |
| Relative Strength Index (RSI) | 39.86 |
| Average Volume (20 Days) | 66,905 |
Short Selling Information
| Short Interest | 45,883 |
| Short Previous Month | 26,345 |
| Short % of Shares Out | 3.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.79M |
| Pretax Income | -6.36M |
| Net Income | -6.32M |
| EBITDA | -6.70M |
| EBIT | -6.79M |
| Earnings Per Share (EPS) | -$13.19 |
Balance Sheet
| Cash & Cash Equivalents | 17.14M |
| Total Debt | n/a |
| Net Cash | 17.14M |
| Net Cash Per Share | $11.37 |
| Equity (Book Value) | 18.44M |
| Book Value Per Share | 12.23 |
| Working Capital | 15.17M |
Cash Flow
| Operating Cash Flow | -4.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.81M |
| FCF Per Share | -$3.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -136.81% |
| Shareholder Yield | -136.81% |
| Earnings Yield | -141.77% |
| FCF Yield | -107.81% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |